{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:55:01Z","timestamp":1793397301600,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtos.2025.03.008","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T14:10:09Z","timestamp":1744121409000},"page":"132-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Acanthamoeba keratitis treatment outcomes compared for drug delivery by protocol versus physician's individualised treatment"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4090-6950","authenticated-orcid":false,"given":"John K.G.","family":"Dart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Rama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Anders","family":"Knutsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saj","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Hau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Franch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Birattari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Fasolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Mrukwa-Kominek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Jadczyk-Sorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Carley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossain","family":"Parwez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darwin C.","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jtos.2025.03.008_bib1","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1136\/bjophthalmol-2013-304660","article-title":"Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials","volume":"98","author":"McDonald","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.008_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/ICO.0000000000001781","article-title":"Management algorithm for fungal keratitis: the TST (topical, systemic, and targeted therapy) protocol","volume":"38","author":"Sharma","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2025.03.008_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtos.2022.04.003","article-title":"Advances in the management of Acanthamoeba keratitis: a review of the literature and synthesized algorithmic approach","volume":"25","author":"Kaufman","year":"2022","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.008_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10030323","article-title":"Acanthamoeba keratitis, pathology, diagnosis and treatment","volume":"10","author":"Fanselow","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.jtos.2025.03.008_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1051\/parasite\/2015010","article-title":"An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment","volume":"22","author":"Lorenzo-Morales","year":"2015","journal-title":"Parasite"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.008_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajo.2009.06.009","article-title":"Acanthamoeba keratitis: diagnosis and treatment update 2009","volume":"148","author":"Dart","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.008_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ophtha.2023.09.031","article-title":"The orphan drug for acanthamoeba keratitis (ODAK) trial: PHMB 0.08% (polihexanide) and placebo versus PHMB 0.02% and propamidine 0.1","volume":"131","author":"Dart","year":"2024","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.008_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bjophthalmol-2019-314485","article-title":"Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases","volume":"104","author":"Papa","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.008_bib9","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0161-6420(03)00481-0","article-title":"Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity","volume":"110","author":"Perez-Santonja","year":"2003","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.008_bib10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/bjo.84.10.1103","article-title":"Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis","volume":"84","author":"Sharma","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.008_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/02713689608997418","article-title":"Effects of polyhexamethylene biguanide and chlorhexidine on four species of Acanthamoeba in vitro","volume":"15","author":"Tirado-Angel","year":"1996","journal-title":"Curr Eye Res"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.008_bib12","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s41433-020-1109-4","volume":"35","author":"Bagga","year":"2021","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.jtos.2025.03.008_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2018.03.007","article-title":"The use of miltefosine in the management of refractory Acanthamoeba keratitis","author":"Tavassoli","year":"2018","journal-title":"Contact Lens Anterior Eye : J Br Contact Lens Assoc"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.008_bib14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/eye.2013.39","article-title":"New insight into non-healing corneal ulcers: iatrogenic crystals","volume":"27","author":"Livingstone","year":"2013","journal-title":"Eye (Lond)."},{"issue":"1","key":"10.1016\/j.jtos.2025.03.008_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2020-000698","article-title":"Chlorhexidine gluconate 0.2% as a treatment for recalcitrant fungal keratitis in Uganda: a pilot study","volume":"6","author":"Arunga","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.008_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/ICO.0000000000002055","article-title":"Synergy testing of antiamoebic agents for acanthamoeba: antagonistic effect of voriconazole","volume":"38","author":"Talbott","year":"2019","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.008_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12866-020-01960-y","article-title":"The combined utilization of Chlorhexidine and Voriconazole or Natamycin to combat Fusarium infections","volume":"20","author":"Jiang","year":"2020","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jtos.2025.03.008_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ajo.2019.08.027","article-title":"Rose bengal photodynamic antimicrobial therapy for patients with progressive infectious keratitis: a pilot clinical study","volume":"208","author":"Naranjo","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.008_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000709","article-title":"Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most","volume":"3","author":"Sunyoto","year":"2018","journal-title":"BMJ Glob Health"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.008_bib20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/ICO.0000000000002849","article-title":"Anterior scleral and limbal inflammatory necrosis after adjuvant miltefosine for recalcitrant acanthamoeba keratitis","volume":"41","author":"de la Presa","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2025.03.008_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajo.2020.09.048","article-title":"Oral miltefosine as salvage therapy for refractory acanthamoeba keratitis","volume":"223","author":"Thulasi","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"7\u20138","key":"10.1016\/j.jtos.2025.03.008_bib22","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1080\/09273948.2020.1758156","article-title":"Systemic miltefosine as an adjunct treatment of progressive acanthamoeba keratitis","volume":"29","author":"Naranjo","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jtos.2025.03.008_bib23","doi-asserted-by":"crossref","first-page":"100555","DOI":"10.1016\/j.ajoc.2019.100555","article-title":"Oral miltefosine for refractory Acanthamoeba keratitis","volume":"16","author":"Hirabayashi","year":"2019","journal-title":"American journal of ophthalmology case reports"},{"issue":"7","key":"10.1016\/j.jtos.2025.03.008_bib24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/ICO.0000000000001968","article-title":"Oral miltefosine as adjunctive treatment for recalcitrant acanthamoeba keratitis","volume":"38","author":"Dewan","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2025.03.008_bib25","first-page":"1","article-title":"Resolution of acanthamoeba keratitis with adjunctive use of oral miltefosine","author":"Avdagic","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jtos.2025.03.008_bib26","article-title":"Efficacy of topical miltefosine in patients with acanthamoeba keratitis: a pilot study","author":"Bagga","year":"2018","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.008_bib27","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.ophtha.2014.06.033","article-title":"Acanthamoeba sclerokeratitis: epidemiology, clinical features, and treatment outcomes","volume":"121","author":"Iovieno","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.008_bib28","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2018.10.018","article-title":"Bacterial keratitis preferred practice pattern(R)","volume":"126","author":"Lin","year":"2019","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.008_bib29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jamaophthalmol.2013.1497","article-title":"The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole","volume":"131","author":"Prajna","year":"2013","journal-title":"JAMA ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.008_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/ICO.0b013e318156caf2","article-title":"Risk factors and causative organisms in microbial keratitis","volume":"27","author":"Green","year":"2008","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.008_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2005.08.013","article-title":"Microbial keratitis predisposing factors and morbidity","volume":"113","author":"Keay","year":"2006","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.008_bib33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ajo.2015.07.028","article-title":"Comparison between polymicrobial and fungal keratitis: clinical features, risk factors, and outcome","volume":"160","author":"Fernandes","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"Pt 6","key":"10.1016\/j.jtos.2025.03.008_bib34","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/eye.1993.168","article-title":"A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992","volume":"7","author":"Bacon","year":"1993","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.008_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222092","article-title":"The rising incidence of Acanthamoeba keratitis: a 7-year nationwide survey and clinical assessment of risk factors and functional outcomes","volume":"14","author":"Randag","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.008_bib36","article-title":"Medical interventions for fungal keratitis","author":"FlorCruz","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.008_bib37","article-title":"Medical interventions for acanthamoeba keratitis","author":"Alkharashi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.008_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/nep.13706","article-title":"Where to look for the most frequent biases?","volume":"25","author":"Jager","year":"2020","journal-title":"Nephrology"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.008_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/tvst.8.5.17","article-title":"In vitro evaluation of the inhibitory effect of topical ophthalmic agents on acanthamoeba viability","volume":"8","author":"Heaselgrave","year":"2019","journal-title":"Transl Vis Sci Technol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T09:57:10Z","timestamp":1764755830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012425000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":38,"alternative-id":["S1542012425000527"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2025.03.008","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acanthamoeba keratitis treatment outcomes compared for drug delivery by protocol versus physician's individualised treatment","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2025.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}